Verde Financial Statements From 2010 to 2025

APHD Stock  USD 0.0001  0.00  0.00%   
Verde Bio financial statements provide useful quarterly and yearly information to potential Verde Bio Holdings investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Verde Bio financial statements helps investors assess Verde Bio's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Verde Bio's valuation are summarized below:
Verde Bio Holdings does not presently have any fundamental trend indicators for analysis.
Check Verde Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Verde Bio's main balance sheet or income statement drivers, such as , as well as many indicators such as . Verde financial statements analysis is a perfect complement when working with Verde Bio Valuation or Volatility modules.
  
This module can also supplement various Verde Bio Technical models . Check out the analysis of Verde Bio Correlation against competitors.

Verde Bio Holdings Company Price To Earning Analysis

Verde Bio's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

P/E

 = 

Market Value Per Share

Earnings Per Share

More About Price To Earning | All Equity Analysis

Current Verde Bio Price To Earning

    
  (0.20) X  
Most of Verde Bio's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Verde Bio Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Competition

Based on the latest financial disclosure, Verde Bio Holdings has a Price To Earning of -0.2 times. This is 101.09% lower than that of the Financial Services sector and significantly lower than that of the Shell Companies industry. The price to earning for all United States stocks is 100.7% higher than that of the company.

Verde Bio Holdings Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Verde Bio's current stock value. Our valuation model uses many indicators to compare Verde Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Verde Bio competition to find correlations between indicators driving Verde Bio's intrinsic value. More Info.
Verde Bio Holdings is rated below average in return on asset category among its peers. It is rated below average in operating margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Verde Bio's earnings, one of the primary drivers of an investment's value.

About Verde Bio Financial Statements

Verde Bio stakeholders use historical fundamental indicators, such as Verde Bio's revenue or net income, to determine how well the company is positioned to perform in the future. Although Verde Bio investors may analyze each financial statement separately, they are all interrelated. For example, changes in Verde Bio's assets and liabilities are reflected in the revenues and expenses on Verde Bio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Verde Bio Holdings. Please read more on our technical analysis and fundamental analysis pages.
The company primarily provides MagCast Publishing Platform, a cloud-based digital publishing software which enables customers to create mobile magazine apps, as well as facilitates the monetization of digital content through advanced marketing functions. Apogee 21 Holdings, Inc. was founded in 2005 and is based in Wheat Ridge, Colorado. Apogee 21 operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 11 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Verde Pink Sheet

Verde Bio financial ratios help investors to determine whether Verde Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Verde with respect to the benefits of owning Verde Bio security.